Prochem Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -8.84%
(FY 2023)
- Profit -29.97%
(FY 2023)
- Ebitda -29.04%
(FY 2023)
- Net Worth 9.89%
(FY 2023)
- Total Assets 2.59%
(FY 2023)
About Prochem Bioceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Arora and Shashank Arora serve as directors at the Company.
- CIN/LLPIN
U24232DL2008PTC179128
- Company No.
179128
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prochem Bioceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Arora  | Director | 05-Jun-2008 | Current |
| Shashank Arora | Director | 16-Jul-2016 | Current |
Financial Performance of Prochem Bioceuticals.
Prochem Bioceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.84% decrease. The company also saw a substantial fall in profitability, with a 29.97% decrease in profit. The company's net worth moved up by a moderate rise of 9.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prochem Bioceuticals?
In 2023, Prochem Bioceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prochem Bioceuticals?
Prochem Bioceuticals has a workforce of 2 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prochem Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prochem Bioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
